Browsing Tag

KAHR

KAHR to Host Key Opinion Leader Webinar on the Potential of CD47 Therapeutics for the…

Eli Pacheco Nov 23, 2021 0

JERUSALEM, Nov. 23, 2021 (GLOBE NEWSWIRE) -- KAHR, a cancer immunotherapy company developing novel multifunctional immune-recruitment proteins, today announced it will host a virtual key…

Business

Israeli cancer drug developer KAHR raises $46.5m

Dustin Moskovitz Jun 20, 2021 0

Israeli cancer immunotherapy developer KAHR today announced the completion of a $46.5 million financing round led by aMoon with participation from new investors BVF…